Politics● LowSep 18 · Sep 18, 2026, 11:08 AM
Trump administration is said to weigh allowing most pharma licensing deals with China
GlobeAlert Desk · curated from Seeking Alpha Tech · global
The Trump administration is reportedly considering a policy change to allow most pharmaceutical licensing deals with China. This potential shift impacts trade relations and the pharmaceutical industry.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text. How we score stories.
GlobeAlert context
What the desk knows about this story
Threat level
1 Low
Scored from severity, scale, escalation potential and source agreement. Below the alert threshold.
Sources
1 publisher
Single-source so far. Treat details as unconfirmed until more publishers report.
Category
Politics
Not flagged as developing.
More in Politics
Politics21m agoDemocrats flip North Carolina's 11th DistrictCBS NewsPolitics23m agoKiros wins Colorado House seat after ousting DeGette in primaryThe HillPolitics23m agoLeavitt says Trump ‘remains cautiously optimistic’The HillPolitics27m agoDemocrats hold onto 3 redistricted Florida seats, CBS News projectsCBS News